Czech Republic avoids security order in plasma saga
The Commercial Court in London has refused to order the Czech Republic to pay security for the award or security for costs while it challenges a US$650 million investment treaty award over a blood plasma business – calling the investors’ costs estimate “absurdly high”.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.